CAPPED BONUSZERTIFIKAT - MEDTRONIC Share Price

Certificat

DE000PC5JV16

Market Closed - Börse Stuttgart 08:03:37 08/05/2024 BST
80.01 EUR +0.46% Intraday chart for CAPPED BONUSZERTIFIKAT - MEDTRONIC
Current month+1.45%
1 month-0.90%
Date Price Change Volume
08/05/24 80.01 +0.46% 0
07/05/24 79.64 +0.19% 0
06/05/24 79.49 +0.62% 0
03/05/24 79 +0.52% 0
02/05/24 78.59 -0.36% 0

Delayed Quote Börse Stuttgart

Last update May 08, 2024 at 08:03 am

More quotes

Static data

Product typeCertificados de Bonus y Protección Parcial
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5JV1
ISINDE000PC5JV16
Date issued 23/02/2024
Strike 95 $
Maturity 20/09/2024 (135 Days)
Parity 1 : 1
Emission price 78.2
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 82.87
Lowest since issue 76.11

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.55 USD
Average target price
94.77 USD
Spread / Average Target
+16.22%
Consensus